Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas
Clinical trial NCT06678373 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06678373
- Sponsor
- Liaoning Chengda Biotechnology CO., LTD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-14
- Primary completion
- 2026-04-30
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.